Beryl Drugs Ltd

AGM Details

• Date and time: 29 September 2026, 11:00 AM.
• Mode: Physical; venue: Kanchan Palace, Indore.

Resolutions and outcomes

• Adopt audited standalone financial statements for year ended 31 Mar 2026; ordinary resolution passed.
• Sudhir Sethi re-appointment as Director; ordinary resolution passed.
• Increase in limit for material related party transactions with Aminova Infusions Ltd; ordinary resolution passed.

Approval details

• Approval at AGM to raise RPT cap with Aminova Infusions from ₹5 crore to ₹8 crore.

AGM Details

• AGM held on 29 September 2026 at 11:00 A.M., Indore, in person.
• Concluded at 11:30 A.M.

Key Resolutions

• Adoption of audited financial statements for FY ended 31 March 2026.
• Reappointment of retiring Director Sudhir Sethi (DIN: 00090172).
• Increase in material related party transaction limit with Aminova Infusions Pvt. Ltd.

Voting Results

• Resolution 1 passed by requisite majority.
• Resolution 2 passed.
• Resolution 3 passed.

Director Changes

• Sudhir Sethi reappointed as director.

Related Party Transactions

• Increase in RPT limit with Aminova Infusions Pvt. Ltd.

Financial highlights

• Total revenue 1882.02 Lakhs for FY25-26.
• Net profit after tax 42.48 Lakhs; EPS 0.84.
• PBT 58.80 Lakhs; comprehensive income 40.67 Lakhs.
• YoY revenue declined from 2114.62 to 1882.02.
• Dividend not declared for the year.
• Shareholders' equity 988.75 Lakhs; retained earnings 474.85 Lakhs.

Revenue drivers & trends

• BFS shutdown in 2025 impacted revenue.
• BFS operations resumed late 2025; normalization pending.
• Delay-supply charges and other variabilities affect revenue.

Balance sheet & capital

• Current borrowings: 239.13 Lakhs; no long-term borrowings.
• Total equity 988.75 Lakhs; retained earnings 474.85 Lakhs.
• Investment property 21.73 Lakhs; ROUs 27.75 Lakhs.
• Total assets: 1496.33 Lakhs.

Cash flows

• Net cash from operating activities: 364.95 Lakhs.
• Net cash used in investing: 216.34 Lakhs.
• Net cash used in financing: 202.69 Lakhs.
• Net decrease in cash and cash equivalents: 54.08 Lakhs.

Related party transactions

• Aminova Infusions Pvt Ltd transactions: 77.30 Lakhs.
• Shareholders approved increase to 8.00 crore for related party limit.
• RPT terms: arm's length; ordinary course; no related party votes.
• Pathak promoter of Aminova; related party since Jan 2026.

Governance & key appointments

• Shailendra Pathak appointed Whole-Time Director; five-year term.
• Neha Sarda appointed Independent Director.
• Kamlesh Gupta appointed Company Secretary.
• Secretarial Auditor Dipika Kataria; no qualifications.

Government grants & CSR

• MSME schemes grants total 246.05 Lakhs deducted from PPE.
• MP MSME 2025 grant: 155.61 Lakhs; 98.64 Lakhs receivable.
• Receivable installments total 143.86 Lakhs.
• CSR not applicable.

Auditors & risk notes

• Statutory auditors: Subhash Chand Jain Anurag & Associates.
• Internal controls adequate; no material weaknesses reported.
• Emphasis: BFS stop noted.

AGM details

• 33rd AGM on 29 September 2026 at 11:00 AM, in-person at Indore.
• Register of members and share transfer books closed 23–29 September 2026.

Ordinary business

• Adoption of audited standalone financial statements for year ended 31 March 2026.
• Re-appointment of Sudhir Sethi as Director, liable to retire by rotation.

Special business – related party transactions

• Increase in aggregate RPT limit with Aminova Infusions Pvt Ltd from 5.00 crore to 8.00 crore.
• Resolution to increase limit is an ordinary resolution; related parties shall not vote.
• Audit Committee recommended the increase; Board approved for Members' approval.
• The two-year tenure remains unchanged.

AGM e-voting details

• Platform: CDSL for remote e-voting; entitlement cut-off 7 September 2026.
• AGM date/time: 29 September 2026 at 11:00 AM.
• Voting start and end: 26 September 2026 09:00 IST to 28 September 2026 17:00 IST.
• Scrutinizer: CS Dipika Kataria, M.No 8078, CP 9526.
• Regulatory basis: Regulation 44, SEBI LODR; Section 108, Companies Act 2013.

Record date and AGM details

• Record date for voting rights: 22 September 2026 for remote e-voting entitlement.
• Annual book closure: 23 September 2026 to 29 September 2026 (inclusive).
• AGM scheduled for 29 September 2026 at 11:00 AM.
• Security type: Equity shares.
• Purpose: Annual General Meeting.

Book closure & AGM details

• Book closure: 23 September 2026 to 29 September 2026 (both days inclusive).
• Purpose: Annual General Meeting.
• Cut-off date for voting entitlement: 22 September 2026.
• AGM date: 29 September 2026 at 11:00 A.M.
• Security type: Equity shares.
• E-voting: remote voting eligibility determined by cut-off.

Key board approvals

• Approved the Board report for the forthcoming AGM.
• Fixed date and approved notice for the 33rd AGM.
• Fixed annual book-closure dates for 33rd AGM.
• Fixed cut-off date and remote e-voting period for ensuing AGM.
• Appointed Dipika Kataria as Scrutinizer for remote e-voting at 33rd AGM.
• Considered and approved increase in related party transaction limit with Aminova Infusions Pvt. Ltd.
• Authorized directors to authenticate and file forms under the Companies Act 2013.